NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.

Author(s): Toro PV, Erlanger B, Beaver JA, Cochran RL, VanDenBerg DA, Yakim E, Cravero K, Chu D, Zabransky DJ, Wong HY, Croessmann S, Parsons H, Hurley PJ, Lauring J, Park BH

Publication: Clin Biochem, 2015, Vol. 48, Page 993-8

PubMed ID: 26234639 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare cell-free DNA levels in plasma among blood specimens collected in different tube types and subjected to a pre-processing delay of 7 days at room temperature.

Conclusion of Paper

Generally, the number of copies of cell-free DNA in plasma were higher when blood was stored for 7 days at room temperature in EDTA or PAXgene tubes, but remained comparable to immediately processed specimens when blood was stored in Streck blood collection tubes (BCT). However, one of the phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) hotspot mutations as well as fetal DNA levels were not affected by the pre-processing delay, regardless of tube type. 

Studies

  1. Study Purpose

    The purpose of this study was to compare the stabilities of fetal and total cell-free DNA in plasma collected from pregnant women. Blood from a pregnant volunteer was collected into EDTA and BCT tubes and was processed by double centrifugation within 2 h or after 7 days at room temperature. Additional blood from another pregnant volunteer was collected into EDTA, BCT and PAXgene tubes. EDTA specimens were processed by double centrifugation within 2 h while PAXgene and BCT specimens were processed after 7 days at room temperature. Cell-free DNA was extracted from the plasma specimens using the QIAamp Circulating Nucleic Acid kit. Fetal DNA was quantified by digital PCR amplification of E1F1AY region of the Y chromosome and total DNA was quantified by amplification of wild-type PIK3CA exon 9.

    Summary of Findings:

    Compared to controls processed within 2 h, the number of copies of total cell-free DNA in plasma was unaffected by a pre-processing delay of 7 days at room temperature when specimens were collected and stored in BCT tubes, but the number of copies increased by >10- and >5-fold when blood was collected and stored in EDTA or PAXgene tubes, respectively. Plasma levels of fetal cell-free DNA were not affected by a pre-processing delay of 7 days at room temperature for any of the tube types examined (EDTA, BCT or PAXgene tubes).

    Biospecimens
    Preservative Types
    • PAXgene
    • None (Fresh)
    • Streck/BCT
    Diagnoses:
    • Pregnant
    Platform:
    AnalyteTechnology Platform
    DNA Digital PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation PAXgene
    Blood collection tube additive
    None (fresh)
    Digital PCR Specific Targeted nucleic acid E1F1AY
    PIK3CA exon 9
    Storage Time at room temperature <2 h
    7 days
    Biospecimen Acquisition Type of collection container/solution PAXgene tube
    BCT tube
    EDTA tube
  2. Study Purpose

    The purpose of this study was to compare wild-type and mutant PIK3CA cell-free DNA levels in plasma among blood specimens collected in different tube types and subjected to a pre-processing delay of 7 days at room temperature. Blood was collected from 9 women with estrogen receptor positive metastatic breast cancer into EDTA, PAXgene and  BCT tubes and were processed by double centrifugation within 2 h or after 7 days (PAXgene and BCT tubes only) at room temperature. Cell-free DNA was extracted from plasma specimens using the QIAamp Circulating Nucleic Acid kit. 

    Summary of Findings:

    When blood collected in PAXgene tubes was subjected to a room temperature pre-processing delay of 7 days, DNA levels in plasma increased by an average of 37.14-fold (range: 0.87-191.60 fold, p<0.0059), but when blood was collected and stored for 7 days in BCT tubes levels only increased by an average of 1.17-fold (range 0.46-2.59 fold, p=0.32). Interestingly, for the 2 patients with an E545K mutation the number of E545K copies in plasma when blood was stored for 7 days was comparable to controls processed within 2 h, regardless of tube type. Conversely, copies of the 1047R mutation in plasma increased 22.79- and 33.22-fold when blood was collected and stored in PAXgene tubes for 7 days.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • PAXgene
    • Streck/BCT
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    DNA Digital PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution PAXgene tube
    BCT tube
    EDTA tube
    Digital PCR Specific Targeted nucleic acid PIK3CA E545K
    PIK3CA 1047R
    PIK3CA wild-type
    Storage Time at room temperature <2 h
    7 days
    Biospecimen Preservation Type of fixation/preservation PAXgene
    None (fresh)
    Blood collection tube additive

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...